These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10562322)

  • 1. Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells.
    Corazza N; Eichenberger S; Eugster HP; Mueller C
    J Exp Med; 1999 Nov; 190(10):1479-92. PubMed ID: 10562322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmembrane tumor necrosis factor is a potent inducer of colitis even in the absence of its secreted form.
    Corazza N; Brunner T; Buri C; Rihs S; Imboden MA; Seibold I; Mueller C
    Gastroenterology; 2004 Sep; 127(3):816-25. PubMed ID: 15362037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of T cell-induced colonic inflammation on epithelial barrier function.
    Suenaert P; Maerten P; Van Assche G; Van Driessche W; Geboes K; Bulteel V; Simaels J; Augustijns P; Ceuppens JL; Rutgeerts P; Perrier C
    Inflamm Bowel Dis; 2010 Aug; 16(8):1322-31. PubMed ID: 20155850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of antigen induced colitis in SCID mice reconstituted with spleen derived memory type CD4(+) CD45RB(+) T cells.
    Kweon MN; Takahashi I; Yamamoto M; Jang MH; Suenobu N; Kiyono H
    Gut; 2002 Mar; 50(3):299-306. PubMed ID: 11839705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of TNFR2 expression by CD4(+) T cells exacerbates experimental colitis.
    Dayer Schneider J; Seibold I; Saxer-Sekulic N; Paredes BE; Saurer L; Mueller C
    Eur J Immunol; 2009 Jul; 39(7):1743-53. PubMed ID: 19551899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal lamina propria retaining CD4+CD25+ regulatory T cells is a suppressive site of intestinal inflammation.
    Makita S; Kanai T; Nemoto Y; Totsuka T; Okamoto R; Tsuchiya K; Yamamoto M; Kiyono H; Watanabe M
    J Immunol; 2007 Apr; 178(8):4937-46. PubMed ID: 17404275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype.
    Claesson MH; Bregenholt S; Bonhagen K; Thoma S; Möller P; Grusby MJ; Leithäuser F; Nissen MH; Reimann J
    J Immunol; 1999 Mar; 162(6):3702-10. PubMed ID: 10092833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-18Rα-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness.
    Holmkvist P; Pool L; Hägerbrand K; Agace WW; Rivollier A
    Eur J Immunol; 2016 Jun; 46(6):1371-82. PubMed ID: 27062602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-helper 17 and interleukin-17-producing lymphoid tissue inducer-like cells make different contributions to colitis in mice.
    Ono Y; Kanai T; Sujino T; Nemoto Y; Kanai Y; Mikami Y; Hayashi A; Matsumoto A; Takaishi H; Ogata H; Matsuoka K; Hisamatsu T; Watanabe M; Hibi T
    Gastroenterology; 2012 Nov; 143(5):1288-1297. PubMed ID: 22850180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-7 is essential for lymphopenia-driven turnover of colitogenic CD4(+) memory T cells in chronic colitis.
    Tomita T; Kanai T; Totsuka T; Nemoto Y; Okamoto R; Tsuchiya K; Sakamoto N; Ohteki T; Hibi T; Watanabe M
    Eur J Immunol; 2009 Oct; 39(10):2737-47. PubMed ID: 19637223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic and protective roles of CD45RB(low) CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse.
    Shimada A; Rohane P; Fathman CG; Charlton B
    Diabetes; 1996 Jan; 45(1):71-8. PubMed ID: 8522063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-7 Is essential for the development and the persistence of chronic colitis.
    Totsuka T; Kanai T; Nemoto Y; Makita S; Okamoto R; Tsuchiya K; Watanabe M
    J Immunol; 2007 Apr; 178(8):4737-48. PubMed ID: 17404253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell-associated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis.
    Ostanin DV; Furr KL; Pavlick KP; Gray L; Kevil CG; Shukla D; D'Souza D; Hoffman JM; Grisham MB
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1706-14. PubMed ID: 17332469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis.
    Kullberg MC; Jankovic D; Gorelick PL; Caspar P; Letterio JJ; Cheever AW; Sher A
    J Exp Med; 2002 Aug; 196(4):505-15. PubMed ID: 12186842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
    Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
    J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAF5 regulates intestinal mucosal Th1/Th17 cell immune responses via Runx1 in colitis mice.
    Li M; Gan C; Zhang R; Wang J; Wang Y; Zhu W; Liu L; Shang J; Zhao Q
    Immunology; 2023 Dec; 170(4):495-509. PubMed ID: 37575027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update: Induction of Inflammatory Bowel Disease in Immunodeficient Mice by Injection of Naïve CD4
    Pearson CF; Maloy KJ
    Curr Protoc; 2024 Jul; 4(7):e1092. PubMed ID: 39007482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice.
    Davidson NJ; Leach MW; Fort MM; Thompson-Snipes L; Kühn R; Müller W; Berg DJ; Rennick DM
    J Exp Med; 1996 Jul; 184(1):241-51. PubMed ID: 8691138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD48 controls T-cell and antigen-presenting cell functions in experimental colitis.
    Abadía-Molina AC; Ji H; Faubion WA; Julien A; Latchman Y; Yagita H; Sharpe A; Bhan AK; Terhorst C
    Gastroenterology; 2006 Feb; 130(2):424-34. PubMed ID: 16472597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis.
    Bloemendaal FM; Levin AD; Wildenberg ME; Koelink PJ; McRae BL; Salfeld J; Lum J; van der Neut Kolfschoten M; Claassens JW; Visser R; Bentlage A; D'Haens GRAM; Verbeek JS; Vidarsson G; van den Brink GR
    Gastroenterology; 2017 Nov; 153(5):1351-1362.e4. PubMed ID: 28756234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.